Skip to Main Content

Paper Details

ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer.
Nat Cancer
8
2023
ALK, ALK NSCLC, ALK antigens, ALK peptides, ALK tumors, ALK tyrosine kinase, ALK-rearranged non-small cell lung cancer, ALK-specific CD8 T cells, Anaplastic lymphoma kinase, CD8, CD8 T, CD8 T cell, CD8 T cells, HLA, HLA-A*02:01, HLA-B*07:02 molecules, NSCLC, human, human ALK peptides, lung tumors, mice, tumors, tyrosine
Author NameAffiliation
Hasmik KeshishianBroad Institute of MIT and Harvard
Steven A CarrBroad Institute of MIT and Harvard
Steven A CarrBroad Institute of MIT and Harvard
Catherine J WuDana-Farber Cancer Institute
Catherine J WuBroad Institute of MIT and Harvard
Catherine J WuBrigham and Women's Hospital
  • 1 - 6

Datasets

Release 1.2